Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05298176 |
| Title | Combining Afatinib and Concurrent Chemotherapy, Followed by Osimertinib and Concurrent Chemotherapy, in Untreated EGFR Positive NSCLC Tumors (COMBINATION) |
| Acronym | COMBINATION |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Amsterdam UMC, location VUmc |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | NLD |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Amsterdam UMC, location VUmc | RECRUITING | Amsterdam | Noord-Holland | 1081 HV | Netherlands | Details |